🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to draw blood from patients with well-defined atop...
Status
Completed
Location
Fraunhofer ITEM im CRC
Start Date
2018-08-16
Trial ID
NCT03665701
Treatments Being Tested
Primary biliary cholangitis (PBC) is a rare, autoimmune, cholestatic liver ...
Status
Recruiting
Location
Ospedali riuniti di Ancona
Start Date
2019-09-19
Trial ID
NCT05151809
Treatments Being Tested
The goal of this interventional study is to describe the care pathway follo...
Status
Not Yet Recruiting
Location
ROSELA _ Médecins du Monde
Start Date
2026-09
Trial ID
NCT07788599
Treatments Being Tested
In recent studies, it has been reported that the renal resistance index is ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-30
Trial ID
NCT07472452
Treatments Being Tested
We aim to analyze whether the "liquid biopsy" model could increase the spec...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2019-10-01
Trial ID
NCT04079699
Treatments Being Tested
Pharmacogenetics is an area of Pharmacology that studies the contribution o...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT02450487
Treatments Being Tested
A total of 22 subjects will be included in the study. The subjects who were...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12
Trial ID
NCT06557447
This is an ancillary laboratory study to collect and bank blood and tissue ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07550049
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested